Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$45.44 - $74.26 $963,782 - $1.58 Million
-21,210 Reduced 1.45%
1,441,455 $94.7 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $172,596 - $337,770
4,170 Added 0.29%
1,462,665 $65.8 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $5.41 Million - $8.45 Million
74,700 Added 5.4%
1,458,495 $106 Million
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $1.36 Million - $1.78 Million
-15,585 Reduced 1.11%
1,383,795 $148 Million
Q1 2022

May 12, 2022

BUY
$94.19 - $124.49 $1.85 Million - $2.44 Million
19,630 Added 1.42%
1,399,380 $155 Million
Q4 2021

Feb 10, 2022

BUY
$119.57 - $139.07 $16.6 Million - $19.3 Million
138,571 Added 11.16%
1,379,750 $177 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $17.7 Million - $23.1 Million
-162,251 Reduced 11.56%
1,241,179 $165 Million
Q2 2021

Aug 12, 2021

SELL
$100.34 - $115.69 $556,887 - $642,079
-5,550 Reduced 0.39%
1,403,430 $152 Million
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $9.26 Million - $11.4 Million
-91,185 Reduced 6.08%
1,408,980 $148 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $170 Million - $208 Million
-1,974,480 Reduced 56.83%
1,500,165 $156 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $104 Million - $132 Million
-1,430,960 Reduced 29.17%
3,474,645 $298 Million
Q2 2020

Aug 13, 2020

SELL
$48.02 - $79.04 $75,391 - $124,092
-1,570 Reduced 0.03%
4,905,605 $360 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $2.07 Million - $3.52 Million
55,970 Added 1.15%
4,907,175 $255 Million
Q4 2019

Feb 13, 2020

BUY
$47.06 - $56.64 $33.9 Million - $40.7 Million
719,325 Added 17.41%
4,851,205 $273 Million
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $3.53 Million - $4.32 Million
74,435 Added 1.83%
4,131,880 $197 Million
Q2 2019

Aug 13, 2019

BUY
$39.26 - $54.21 $5.65 Million - $7.8 Million
143,945 Added 3.68%
4,057,445 $220 Million
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $2.23 Million - $3.28 Million
74,670 Added 1.95%
3,913,500 $159 Million
Q4 2018

Feb 13, 2019

SELL
$29.95 - $46.34 $1.87 Million - $2.89 Million
-62,415 Reduced 1.6%
3,838,830 $120 Million
Q3 2018

Nov 13, 2018

BUY
$40.12 - $45.55 $5.75 Million - $6.53 Million
143,345 Added 3.81%
3,901,245 $178 Million
Q2 2018

Aug 13, 2018

BUY
$38.72 - $42.52 $5.05 Million - $5.55 Million
130,510 Added 3.6%
3,757,900 $157 Million
Q1 2018

May 14, 2018

BUY
$39.4 - $47.39 $23 Million - $27.7 Million
583,675 Added 19.18%
3,627,390 $149 Million
Q4 2017

Feb 12, 2018

BUY
$37.27 - $43.02 $11.1 Million - $12.8 Million
298,015 Added 10.85%
3,043,715 $125 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $92.7 Million - $114 Million
2,745,700
2,745,700 $110 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Champlain Investment Partners, LLC Portfolio

Follow Champlain Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.